Literature DB >> 18503974

First successful bridge to myocardial recovery with a HeartWare HVAD.

Clare Wood1, Andrew Maiorana, Robert Larbalestier, Michael Lovett, Gillian Green, Gerry O'Driscoll.   

Abstract

In this report we describe the first successful bridge to myocardial recovery with the HeartWare HVAD. Assessment for explantation included serial echocardiography, hemodynamic monitoring, metabolic analysis and manipulation of pump speed, both at rest and during exercise. A protocol for assessing the degree of myocardial recovery without stopping the device is described.

Mesh：

Year:  2008        PMID： 18503974     DOI： 10.1016/j.healun.2008.03.007

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


  5 in total

Review 1.  Mechanical circulatory support.

Authors:  Deborah J Kozik; Mark D Plunkett
Journal:  Organogenesis       Date:  2011-01-01       Impact factor: 2.500

Review 2.  Current status of third-generation implantable left ventricular assist devices in Japan, Duraheart and HeartWare.

Authors:  Yoshiki Sawa
Journal:  Surg Today       Date:  2014-08-21       Impact factor: 2.549

3.  Mechanical circulatory support-results, developments and trends.

Authors:  Thomas Krabatsch; Martin Schweiger; Alexander Stepanenko; Marian Kukucka; Juliane Vierecke; Hans B Lehmkuhl; Michael Huebler; Ewald Hennig; Evgenij Potapov; Roland Hetzer
Journal:  J Cardiovasc Transl Res       Date:  2011-03-11       Impact factor: 4.132

4.  An innovative, sensorless, pulsatile, continuous-flow total artificial heart: device design and initial in vitro study.

Authors:  Kiyotaka Fukamachi; David J Horvath; Alex L Massiello; Hideyuki Fumoto; Tetsuya Horai; Santosh Rao; Leonard A R Golding
Journal:  J Heart Lung Transplant       Date:  2009-09-26       Impact factor: 10.247

5.  HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation: a comparative analysis.

Authors:  Veli K Topkara; James K O'Neill; Adam Carlisle; Eric Novak; Scott C Silvestry; Gregory A Ewald
Journal:  Ann Thorac Surg       Date:  2013-10-17       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.